The rates of acid production were compared in thin strips of muscle biopsy samples isolated from malignant hyperpyrexia and control vastus internus human muscle. Halothane doubled the rate of acid production by malignant hyperpyrexia susceptible muscle but had no effect on control samples. This increased rate of release of acid from muscle was not from lactate. In addition, the pyruvate dehydrogenase activity of both control and malignant hyperpyrexia muscle samples was not stimulated by halothane.
Malignant hyperpyrexia (MH) is an autosomal dominant disease characterized by a progressively increasing body temperature, hyperkalaemia, lacticacidosis and muscle contracture in response to certain volatile anaesthetic agents (especially halothane) and depolarizing muscle relaxants (Britt and Kalow, 1970) . Although the fundamental defect in MH is obscure it has been suggested that the calcium accumulating capacity of the mitochondrion (Britt, Kalow and Endrenyi, 1973) or the sarcoplasmic reticulum (Britt et al., 1973) is defective in the presence of anaesthetic agents. The resulting increase in the myoplasmic calcium concentration may activate glycolysis (by activating phosphorylase), activate the citric acid cycle (by activating pyruvate dehydrogenase), stimulate the myosin ATPase and uncouple mitochondria (Britt, Kalow and Endrenyi, 1973) .
Although calcium uptake by sarcoplasmic reticulum vesicles isolated from MH muscle has been investigated (Dhalla et al., 1972; Britt, Kalow and Endrenyi, 1973 ) the results have been ambiguous (Isaacs and Heffron, 1975) and so far no definite alteration in the biochemistry of MH muscle has been defined. Although suggested by work with porcine MH (Lucke, Hall and Lister, 1976), it has not been actually demonstrated that the clinical effects which have been observed in the human MH condition (acidosis, increasing body temperature, etc.) occur within the skeletal muscles of the affected patient. In order to test if acidosis originates from the muscle tissue itself, we have made use of the observation of Ellis and colleagues (1971) who have shown that the halothaneinduced isometric contracture of isolated MH muscle may be used as a test for the diagnosis of MH susceptibility. We have shown that halothane induces an increased rate of acid production in MH muscle while the rate is unchanged in control samples. In addition, we have demonstrated that this acidity is not associated with increased lactate production or pyruvate dehydrogenase (PDH) activity.
METHODS
Patients were selected for investigation if they required screening for MH following an episode of MH in the family. Individual portions of left vastus internus muscle were used for in vitro halothane contracture testing (Ellis et al., 1971) , histopathological study (Harriman, Sumner and Ellis, 1973) and biochemical measurements. The results of the former two investigations indicated if the patient had MH susceptibility.
For the measurement of acid production strips of biopsied muscle, approximately 20 mm long by 1 mm in diameter, were secured on thin perspex rods which were slightly longer than the strips of muscle. These were placed in a 5-ml titration cell of a Radiometer TTT60 autotitrator assembly. The muscle samples were oxygenated continuously in 4 ml of a modified For the measurement of the development of contracture (Ellis et al., 1971) , similar muscle strips were assembled in a tissue bath in Krebs solution at 37 °C. The upper end was attached to an isometric force transducer which was positioned to submit the muscle to a 2-g resting load. After 1-2 min halothane was admitted to the tissue bath in a 95%-5% oxygen-carbon dioxide gas mixture. Muscle viability was monitored by recording concurrently the muscle twitch in response to supramaximal electrical square wave stimulation (1 ms duration at approximately 40 V at 0.5 Hz).
For the production of lactic acid, muscle was immersed in fresh buffer in the titrator and after acid production had started, the muscle was incubated for 10 min in the presence or absence of halothane. With MH samples, we ensured that the halothane-induced increase in the rate of acid production was maintained for the full 10 min of incubation. Buffer was then removed and triplicate samples were assayed for lactic acid (Bergmeyer, 1963) . For the determination of PDH activity, muscle samples were treated in a manner similar to those used for the lactic acid determinations. After 10 min acid production (with or without halothane) muscle samples were removed rapidly from the titration assembly and frozen in liquid nitrogen. These samples were powdered in liquid nitrogen and then homogenized at 0 °C in potassium phosphate buffer 50 mmol litre-1 (pH 7.5) containing EDTA 5 mmol litre"
1 .
This EDTA chelates any ionized calcium released from the muscle during homogenization, thus preventing any further activation of the PDH phosphatase and consequent increased PDH activity. Thus the presence of EDTA in the homogenizing medium assures that the PDH activity measured actually reflects the activity in the intact muscle as determined by its degree of phosphorylation/ dephosphorylation. A portion of this homogenate was incubated at room temperature for 30 min with CaCl 2 5 mmol litre-1 and MgCl 2 7.5 mmol litre-1 which eventually converts all the PDH into the active dephosphorylated form. The PDH activity of the muscle homogenate in both media was assayed as described by Illingworth and Mullings (1976a, b) . All assays were performed in duplicate and the data reported are the mean values.
RESULTS
The effect of halothane on the rate of acid production by muscle samples is shown in figure 1 . It is clear that, while for MH muscle this rate is stimulated markedly by halothane, the control sample is unaffected. In these experiments it was important to use physiologically active, restrained pieces of muscle. When small "chunks" of muscle, of weight similar to the samples described in figure 1, were substituted, no effect of halothane on MH muscle was observed. The average increase in the rate of production of acid was significantly different for MH muscle samples in comparison with control muscle samples (table I) . Also shown in figure 1 is the isometric tension developed by similar muscle samples under conditions similar to those used for investigating the rate of acid production. Only MH samples developed increased tension in the presence of halothane. Almost all the acidity in muscle arises from either lactic acid during anaerobic glycolysis or as carbon dioxide from the citric acid cycle under aerobic conditions (Lehninger, 1975) . We have examined the source of the acid production described in figure 1A by two methods. The first involved measurement of lactate production in the titrator assembly. The second involved measurement of PDH activity in separate muscle samples exposed or not exposed to halothane. PDH is the key enzyme regulating entry of acetyl CoA from glycolysis into the citric acid cycle. In addition to being inhibited by its products (NADH and acetyl CoA), PDH can exist in either phosphorylated or dephosphorylated forms (Wieland et al.,1973) . PDH is phosphorylated by PDH kinase to produce a catalytically inactive form of PDH. Inactive phosphorylated PDH is reactivated by the action of PDH phosphatase which catalyses the hydrolytic removal of the inhibitory phosphate groups. This PDH phosphatase is stimulated when the Ca 2+ concentration increases from 10~8 to 10~5 mol litre"" 1 (conditions whichproduce activation of the actomyosin ATPasein muscle) (Ebashi and Endo, 1968 
DISCUSSION
We have demonstrated that the acidosis observed in the human MH condition is accompanied by an increased rate of acid production by the muscle itself ( fig. 1 ). This increased acid production does not arise from increased lactate production (table II) . Since lactate production is unaltered, the increased rate of acid production by halothane treatment of MH muscle cannot result from an increased rate of anaerobic glycolysis. PDH activities of MH and control muscle samples are unaffected by previous treatment of the muscles with halothane (table II) . Thus, since PDH activity is unaltered in MH muscle, aerobic glycolysis is not responsible for the observed increase in acid production. Although glucose metabolism may be increased by futile cycling similar to that observed in porcine MH (Clark et al., 1973) , this would not explain the increased acid production described here. Isaacs and Heffron (1975) demonstrated that there were reduced concentrations of phosphocreatine and ATP and increased concentration of glucose-6-phosphate in the muscle of MHsusceptible patients. From this they concluded that there might be an increased glycolytic flux in the muscles of these patients, and this view is contrary to our conclusions reported here. There is considerable variation in the concentrations of metabolites in muscle isolated from different individuals (for example Bennett et al.,1977 , for calcium variation and table II of this article for resting rates of lactate and PDH activities). Thus, to determine if there are differences in concentrations of metabolites in control and MH muscle it is more accurate to measure changes in metabolite/enzyme activities of MH muscle before and after halothane exposure (Isaacs and Heffron based their results on only three MH patients).
As discussed above, the PDH kinase is sensitive to Ca 2+ in such a way that increasing the Ca 2+ concentrationfrom 10~8 to 10~5 mol litre" 1 "turns on" the phosphatase which in turn converts PDH from the phosphorylated (inactive) to the dephosphorylated (active) form (Wielandetal., 1973) . In the intact muscle PDH is located on the inner mitochondrial membrane and so, in order for Ca 2+ to activate the phosphatase, Ca 2+ has to penetrate this membrane in order to interact with the phosphatase. However, the mitochondrion has a very active Ca 2+ pump, so that any increase in myoplasmic Ca 2+ that is not immediately reduced by the sarcoplasmic reticulum will be handled by the mitochondria, which will rapidly sequester this excess myoplasmic Ca 2+ . In turn, the Ca 2+ now inside the mitochondria will activate the phosphatase, stimulate PDH activity and thus increase acetyl CoA production. Since Ca 2+ also triggers muscle contraction, the ATP concentration in muscle will decrease, NADH/NAD+ will decrease, initiating activation of the citric acid cycle so that the increased acetyl CoA production will be utilized in carbon dioxide production. Our observation that PDH activity was not increased indicates myoplasmic Ca 2+ concentrations are normal in MH muscle. If there were a halothane-induced deficiency in MH sarcoplasmic reticulum Ca 2+ pumping activity, myoplasmic Ca 2+ concentrations would be increased during the addition of halothane and so activation of PDH should have been observed, but it was not. Thus our results do not support the concept (Britt, Kalow and Endrenyi, 1973) that there is an increased myoplasmic and thus mitochondrial calcium concentration in halothane-treated MH muscle.
An alternative explanation for the increased acid production could be that we are observing increased acetyl CoA production from fatty acid oxidation. This enters the citric acid cycle and produces carbon dioxide evolution. However, our medium does not contain any fatty acids, although it does contain glucose. Thus any fatty acid oxidation occurring must result from oxidation of endogenous lipids stored in the muscle tissue. Although it is possible that the stimulation of acid production is entirely produced by increased oxidation of fatty acids, it has been shown in heart (Illingworth and Mullings, 1976b) that PDH activity increases synchronously as cardiac work output increases. Thus, at least in heart, PDH can exercise effective control over citric acid cycle flux during a work transition or stress (such as occurs on exposure of MH muscle to halothane).
A further possible source of acid production observed with MH muscle is that halothane modifies one of the ion transport processes in the plasma membrane of MH muscle so that protons are extruded from the muscle concomitant with the alkalinization of the muscle itself. This concept is supported by the fact that we did not observe the halothane stimulation in acid production by MH muscle when it had been cut up into chunks. Possibly, the destruction of the plasma membrane, such as occurs on chopping up muscle, destroys the ability of MH muscle to respond to halothane. Thus, the increased rate of acid production (shown in figure 1 ) could result from this type of modification and not a primary alteration in the metabolism of the muscle. Although demonstrated in the porcine model of MH (Lucke, Hall and Lister, 1976 ) the heat observed in human MH syndrome may be a separate phenomenon not necessarily responsible for the observed increased rate of acid production seen in our experiments.
RESUME
On a compare les taux de production d'acide sur des echantillons, obtenus par biopsie, de fines bandes de muscle isole du muscle humain sensible a l'hyperpyrexie maligne et du muscle humain vaste interne tEmoin. L'halothane a double le taux d'acide produit par le muscle sensible a l'hyperpyrexie maligne, mais il n'a eu aucun effet sur les echantillons temoins. L'augmentation du taux de degagement d'acide par le muscle n'a pas ete fonction du lactate. En outre, l'activite pyruvate-deshydrogenase des Echantillons de muscle temoin et de muscle sensible a l'hyperpyrexie maligne n'a pas ete stimulee par l'halothane. 
SUMARIO
Se compar6 la rapidez de producci6n de acido entxe muestras tomadas por biopsia de delgadas tiras de musculo aisladas de hiperpirexia maligna y de musculo humano vasto interno de control. El halotano redoblo la rapidez de la production de acido por el musculo susceptible a hiperpirexia maligna, pero no ejerci6 efecto alguno sobre las muestras de control. Esta mayor rapidez de la liberation de acido del musculo no se debi6 al lactato. Ademas, la actividad del piruvato dehidrogenasa tanto de las muestras de musculo de control como de hiperpirexia maligna no fue estimulada por el halotano.
